November 8, 2018
Making appointments and paying bills for a parent with Alzheimer’s. Managing medicines for a child with cystic fibrosis. Grocery shopping for a neighbor with Parkinson’s. All of these are forms of caregiving. And during National Family Caregivers Month this November, Caregiver Action Network is calling on caregivers to “supercharge” these functions through technology.
November 1, 2018
An upcoming meeting will give people with movement disorders a chance to tell Food and Drug Administration regulators their story – the story of their physical symptoms as well as their emotional ones.
October 9, 2018
That’s why this Mental Illness Awareness Week carries a bold call to action: #CureStigma.
October 2, 2018
Oklahoma is leading the nation when it comes to innovative drug pricing approaches.
August 30, 2018
Patient access developments didn’t stop for summer. As we head into fall, here are 10 quotes from the news items – and new materials – that kept the health policy conversation lively during summer 2018.
August 22, 2018
Last month, the federal government proposed changes to Medicare’s billing rules. The net effect: Doctors will spend less time with their patients. As a physician myself, I know that’s not necessarily a good thing.
August 7, 2018
Existing therapies help Parkinson’s patients control their tremors and stiffness – most of the time. Now, new versions of the drug apormorphine could address breakthrough symptoms, which about 90 percent of patients experience during what’s known as “off” periods.
May 29, 2018
Many people think they know Tourette syndrome. It’s the person who blurts out foul words at inopportune times, like what you see on sitcoms or in movies. In reality, this particular vocal tic is rare. But the stereotype of people living with Tourette syndrome is unfortunately common.
May 11, 2018
This month, patients with Huntington’s disease are asking for what worked for patients with ALS and other debilitating diseases–parity to accessing Medicare benefits. The request is a focal point for May’s Huntington’s Disease Awareness Month.
May 2, 2018
It’s a new drug, but the same old story. The Institute for Clinical and Economic Review recently reported that preventive treatments for migraine may not, in their interpretation, be cost effective. Known as CGGRP inhibitors, the drugs offer patients and health care providers the chance to not just treat but prevent debilitating migraine headaches.
